Full company details

Exosens Continues Growth with Phasics Acquisition

BioPhotonics
Nov/Dec 2025Imaging and detection solutions developer Exosens will acquire wavefront sensing technology company Phasics. The deal expands Exosens' portfolio of offerings targeting defense, industrial control, and the life sciences. Financial terms of the purchase were not disclosed.

Jérôme Cerisier, CEO of Exosens, said that the deal represents a continuation of the company's planned development of its "multi-sensors approach," adding new functionalities to its imaging business. The combined expertise of the companies will allow Exosens to consolidate its position in applications such as optical microscopy and free space optics, he said.

Palaiseau, France-based Phasics offers optical metrology and imaging solutions that range from standalone wavefront sensors to fully automated test benches with proprietary software. According to company CEO Marie-Begona Lebrun, the deal will allow Phasics and its 40 employees to scale up production and extend global reach.

For Exosens, the deal follows a flurry of acquisitions dating to December 2022, when it announced an agreement to acquire Xenics. Since the Xenics purchase, the company has acquired NVLS, Noxant, LR Tech, Centronic, El-Mul, ProxiVision, and Telops.

Exosens, which formerly operated as Photonis, rebranded in 2023 and launched an IPO in June 2024. The company of more than 1800 employees operates 11 sites, in Europe and North America.More news & features